The Biological Technologies Office is holding a Proposers Day meeting and webinar covering the new Personalized Protective Biosystem (PPB) program. PPB aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against chemical and biological threats. The program comprises two technical areas: 1) reactive materials that prevent threat agent access to the body; 2) a configurable barrier countermeasure that neutralizes threat agents at vulnerable points of entry (i.e., skin, airway, ocular).
Additional details, including registration instructions, are available at https://go.usa.gov/xp8dU. The registration deadline is November 26, 2019, at 12:00 PM EST or when capacity is reached. We will continue to accept webinar only registrations through December 2, 2019, or until webinar capacity is reached.
Please address administrative questions to DARPA-SNfirstname.lastname@example.org and refer to the PPB Proposers Day (DARPA-SN-20-10) in all correspondence.
DARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore, the PPB Proposers Day is open only to registered potential applicants, and not to the media or general public.
DARPA anticipates sharing additional program details in a forthcoming Broad Agency Announcement to be posted to the https://beta.sam.gov/ website.
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue